the hospital company (swindon & marlborough) limited
the hospital company (swindon & marlborough) limited Company Information
Company Number
03824242
Next Accounts
Dec 2025
Industry
Medical nursing home activities
Shareholders
hospital company swindon & marlborough holdings ltd
Group Structure
View All
Contact
Registered Address
third floor broad quay house, prince street, bristol, BS1 4DJ
Website
www.thehospitalgroup.orgthe hospital company (swindon & marlborough) limited Estimated Valuation
Pomanda estimates the enterprise value of THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED at £29.4m based on a Turnover of £35.1m and 0.84x industry multiple (adjusted for size and gross margin).
the hospital company (swindon & marlborough) limited Estimated Valuation
Pomanda estimates the enterprise value of THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED at £28.8m based on an EBITDA of £4.9m and a 5.9x industry multiple (adjusted for size and gross margin).
the hospital company (swindon & marlborough) limited Estimated Valuation
Pomanda estimates the enterprise value of THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED at £5m based on Net Assets of £1.8m and 2.82x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Hospital Company (swindon & Marlborough) Limited Overview
The Hospital Company (swindon & Marlborough) Limited is a live company located in bristol, BS1 4DJ with a Companies House number of 03824242. It operates in the medical nursing home activities sector, SIC Code 86102. Founded in August 1999, it's largest shareholder is hospital company swindon & marlborough holdings ltd with a 100% stake. The Hospital Company (swindon & Marlborough) Limited is a mature, large sized company, Pomanda has estimated its turnover at £35.1m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Hospital Company (swindon & Marlborough) Limited Health Check
Pomanda's financial health check has awarded The Hospital Company (Swindon & Marlborough) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
3 Weak
Size
annual sales of £35.1m, make it larger than the average company (£3.8m)
£35.1m - The Hospital Company (swindon & Marlborough) Limited
£3.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 9%, show it is growing at a faster rate (7.4%)
9% - The Hospital Company (swindon & Marlborough) Limited
7.4% - Industry AVG
Production
with a gross margin of 18.9%, this company has a higher cost of product (37.7%)
18.9% - The Hospital Company (swindon & Marlborough) Limited
37.7% - Industry AVG
Profitability
an operating margin of 13.9% make it as profitable than the average company (12.2%)
13.9% - The Hospital Company (swindon & Marlborough) Limited
12.2% - Industry AVG
Employees
with 709 employees, this is above the industry average (99)
- The Hospital Company (swindon & Marlborough) Limited
99 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- The Hospital Company (swindon & Marlborough) Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £49.6k, this is equally as efficient (£49.6k)
- The Hospital Company (swindon & Marlborough) Limited
£49.6k - Industry AVG
Debtor Days
it gets paid by customers after 5 days, this is earlier than average (21 days)
5 days - The Hospital Company (swindon & Marlborough) Limited
21 days - Industry AVG
Creditor Days
its suppliers are paid after 75 days, this is slower than average (21 days)
75 days - The Hospital Company (swindon & Marlborough) Limited
21 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - The Hospital Company (swindon & Marlborough) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 13 weeks, this is less cash available to meet short term requirements (31 weeks)
13 weeks - The Hospital Company (swindon & Marlborough) Limited
31 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 98.6%, this is a higher level of debt than the average (45.1%)
98.6% - The Hospital Company (swindon & Marlborough) Limited
45.1% - Industry AVG
THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED financials
The Hospital Company (Swindon & Marlborough) Limited's latest turnover from March 2024 is £35.1 million and the company has net assets of £1.8 million. According to their latest financial statements, we estimate that The Hospital Company (Swindon & Marlborough) Limited has 709 employees and maintains cash reserves of £7.8 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 35,140,000 | 31,264,000 | 28,307,000 | 26,949,000 | 23,433,000 | 21,035,000 | 20,877,000 | 19,028,000 | 18,810,000 | 19,619,000 | 18,679,000 | 16,021,000 | 16,732,000 | 15,356,000 | 14,074,000 |
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost Of Sales | 28,511,000 | 26,185,000 | 24,586,000 | 22,528,000 | 18,683,000 | 15,490,000 | 17,354,000 | 16,290,000 | 15,925,000 | 16,637,000 | 15,420,000 | 14,468,000 | 15,513,000 | 14,585,000 | 13,552,000 |
| Gross Profit | 6,629,000 | 5,079,000 | 3,721,000 | 4,421,000 | 4,750,000 | 5,545,000 | 3,523,000 | 2,738,000 | 2,885,000 | 2,982,000 | 3,259,000 | 1,553,000 | 1,219,000 | 771,000 | 522,000 |
| Admin Expenses | 1,753,000 | 1,352,000 | 963,000 | 1,255,000 | 1,470,000 | 1,392,000 | 1,215,000 | 1,200,000 | 1,437,000 | 1,208,000 | 1,102,000 | 1,374,000 | 935,000 | 750,000 | 1,233,000 |
| Operating Profit | 4,876,000 | 3,727,000 | 2,758,000 | 3,166,000 | 3,280,000 | 4,153,000 | 2,308,000 | 1,538,000 | 1,448,000 | 1,774,000 | 2,157,000 | 179,000 | 284,000 | 21,000 | -711,000 |
| Interest Payable | 6,856,000 | 6,749,000 | 7,134,000 | 7,478,000 | 8,394,000 | 9,037,000 | 9,595,000 | 9,969,000 | 10,480,000 | 11,059,000 | 11,524,000 | 11,793,000 | 12,031,000 | 12,134,000 | 12,155,000 |
| Interest Receivable | 9,155,000 | 8,623,000 | 9,208,000 | 9,933,000 | 10,680,000 | 11,193,000 | 11,648,000 | 12,099,000 | 12,475,000 | 12,832,000 | 13,148,000 | 13,532,000 | 13,685,000 | 13,786,000 | 14,001,000 |
| Pre-Tax Profit | 9,050,000 | 7,476,000 | 6,707,000 | 7,496,000 | 7,444,000 | 8,181,000 | 6,236,000 | 5,543,000 | 5,319,000 | 5,422,000 | 5,656,000 | 3,793,000 | 3,813,000 | 3,548,000 | 3,010,000 |
| Tax | -2,373,000 | -1,532,000 | -3,898,000 | -1,345,000 | -1,688,000 | -1,481,000 | -1,245,000 | -380,000 | -338,000 | -923,000 | -462,000 | -288,000 | -433,000 | -425,000 | -463,000 |
| Profit After Tax | 6,677,000 | 5,944,000 | 2,809,000 | 6,151,000 | 5,756,000 | 6,700,000 | 4,991,000 | 5,163,000 | 4,981,000 | 4,499,000 | 5,194,000 | 3,505,000 | 3,380,000 | 3,123,000 | 2,547,000 |
| Dividends Paid | 3,893,000 | 4,938,000 | 1,890,000 | 5,144,000 | 10,202,000 | 1,890,000 | 2,784,000 | 6,744,000 | 7,216,000 | 3,398,000 | 4,890,000 | 1,890,000 | 2,846,000 | 2,980,000 | 3,440,000 |
| Retained Profit | 2,784,000 | 1,006,000 | 919,000 | 1,007,000 | -4,446,000 | 4,810,000 | 2,207,000 | -1,581,000 | -2,235,000 | 1,101,000 | 304,000 | 1,615,000 | 534,000 | 143,000 | -893,000 |
| Employee Costs | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Number Of Employees | 3 | 4 | 4 | 4 | 3 | 3 | |||||||||
| EBITDA* | 4,876,000 | 3,727,000 | 2,758,000 | 3,166,000 | 3,280,000 | 4,153,000 | 2,308,000 | 1,538,000 | 1,448,000 | 1,774,000 | 2,157,000 | 179,000 | 284,000 | 21,000 | -711,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 | 31,246,000 |
| Debtors (Due After 1 year) | 62,620,000 | 73,335,000 | 83,057,000 | 91,853,000 | 99,786,000 | 106,916,000 | 113,298,000 | 119,533,000 | 125,131,000 | 131,307,000 | 132,335,000 | 135,694,000 | 138,557,000 | 140,989,000 | 143,009,000 |
| Total Fixed Assets | 93,866,000 | 104,581,000 | 114,303,000 | 123,099,000 | 131,032,000 | 138,162,000 | 144,544,000 | 150,779,000 | 156,377,000 | 162,553,000 | 163,581,000 | 166,940,000 | 169,803,000 | 172,235,000 | 174,255,000 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 553,000 | 157,000 | 801,000 | 785,000 | 480,000 | 287,000 | 194,000 | 5,417,000 | 4,780,000 | 1,464,000 | 743,000 | 89,000 | 8,000 | 548,000 | 268,000 |
| Group Debtors | 3,748,000 | 1,874,000 | 0 | 25,000 | 6,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10,397,000 | 8,522,000 | 8,617,000 |
| Misc Debtors | 14,823,000 | 11,399,000 | 11,800,000 | 11,416,000 | 9,820,000 | 6,532,000 | 5,818,000 | 2,299,000 | 2,089,000 | 6,257,000 | 5,416,000 | 4,964,000 | 4,739,000 | 4,092,000 | 1,638,000 |
| Cash | 7,791,000 | 1,695,000 | 13,508,000 | 21,212,000 | 10,422,000 | 20,169,000 | 13,030,000 | 7,925,000 | 10,503,000 | 12,983,000 | 12,877,000 | 13,910,000 | 12,434,000 | 10,934,000 | 9,377,000 |
| misc current assets | 9,009,000 | 11,755,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 35,924,000 | 26,880,000 | 26,109,000 | 33,438,000 | 20,728,000 | 26,988,000 | 19,042,000 | 15,641,000 | 17,372,000 | 20,704,000 | 19,036,000 | 18,963,000 | 27,578,000 | 24,096,000 | 19,900,000 |
| total assets | 129,790,000 | 131,461,000 | 140,412,000 | 156,537,000 | 151,760,000 | 165,150,000 | 163,586,000 | 166,420,000 | 173,749,000 | 183,257,000 | 182,617,000 | 185,903,000 | 197,381,000 | 196,331,000 | 194,155,000 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 5,902,000 | 2,157,000 | 6,273,000 | 5,081,000 | 4,339,000 | 238,000 | 2,046,000 | 4,014,000 | 3,713,000 | 4,703,000 | 4,164,000 | 3,374,000 | 3,495,000 | 3,670,000 | 3,291,000 |
| Group/Directors Accounts | 4,516,000 | 2,695,000 | 2,148,000 | 722,000 | 699,000 | 3,655,000 | 1,648,000 | 764,000 | 695,000 | 673,000 | 499,000 | 653,000 | 11,048,000 | 9,135,000 | 7,241,000 |
| other short term finances | 10,999,000 | 8,907,000 | 7,221,000 | 7,069,000 | 7,769,000 | 6,547,000 | 6,897,000 | 5,663,000 | 5,083,000 | 4,865,000 | 5,275,000 | 4,903,000 | 4,211,000 | 3,110,000 | 2,626,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 7,783,000 | 6,132,000 | 3,050,000 | 16,752,000 | 4,721,000 | 6,013,000 | 4,528,000 | 3,130,000 | 2,934,000 | 4,797,000 | 4,531,000 | 4,881,000 | 3,567,000 | 3,253,000 | 2,564,000 |
| total current liabilities | 29,200,000 | 19,891,000 | 18,692,000 | 29,624,000 | 17,528,000 | 16,453,000 | 15,119,000 | 13,571,000 | 12,425,000 | 15,038,000 | 14,469,000 | 13,811,000 | 22,321,000 | 19,168,000 | 15,722,000 |
| loans | 84,526,000 | 97,173,000 | 111,915,000 | 120,776,000 | 132,487,000 | 143,286,000 | 151,793,000 | 167,506,000 | 174,022,000 | 182,516,000 | 147,955,000 | 153,378,000 | 158,097,000 | 162,182,000 | 165,170,000 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 6,792,000 | 8,217,000 | 10,763,000 | 12,545,000 | 14,180,000 | 17,172,000 | 15,715,000 | 15,459,000 | 14,593,000 | 12,767,000 | 12,698,000 | 11,985,000 | 12,137,000 | 11,122,000 | 9,972,000 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 7,493,000 | 8,421,000 | 6,665,000 | 4,485,000 | 3,225,000 | 2,356,000 | 1,518,000 | 0 | 0 | 0 | 4,114,000 | 3,652,000 | 3,364,000 | 2,931,000 | 2,506,000 |
| total long term liabilities | 98,811,000 | 113,811,000 | 129,343,000 | 137,806,000 | 149,892,000 | 162,814,000 | 169,026,000 | 182,965,000 | 188,615,000 | 195,283,000 | 164,767,000 | 169,015,000 | 173,598,000 | 176,235,000 | 177,648,000 |
| total liabilities | 128,011,000 | 133,702,000 | 148,035,000 | 167,430,000 | 167,420,000 | 179,267,000 | 184,145,000 | 196,536,000 | 201,040,000 | 210,321,000 | 179,236,000 | 182,826,000 | 195,919,000 | 195,403,000 | 193,370,000 |
| net assets | 1,779,000 | -2,241,000 | -7,623,000 | -10,893,000 | -15,660,000 | -14,117,000 | -20,559,000 | -30,116,000 | -27,291,000 | -27,064,000 | 3,381,000 | 3,077,000 | 1,462,000 | 928,000 | 785,000 |
| total shareholders funds | 1,779,000 | -2,241,000 | -7,623,000 | -10,893,000 | -15,660,000 | -14,117,000 | -20,559,000 | -30,116,000 | -27,291,000 | -27,064,000 | 3,381,000 | 3,077,000 | 1,462,000 | 928,000 | 785,000 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | 4,876,000 | 3,727,000 | 2,758,000 | 3,166,000 | 3,280,000 | 4,153,000 | 2,308,000 | 1,538,000 | 1,448,000 | 1,774,000 | 2,157,000 | 179,000 | 284,000 | 21,000 | -711,000 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -2,373,000 | -1,532,000 | -3,898,000 | -1,345,000 | -1,688,000 | -1,481,000 | -1,245,000 | -380,000 | -338,000 | -923,000 | -462,000 | -288,000 | -433,000 | -425,000 | -463,000 |
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -5,021,000 | -8,893,000 | -8,421,000 | -6,013,000 | -3,643,000 | -5,575,000 | -7,939,000 | -4,751,000 | -7,028,000 | 534,000 | -2,253,000 | -12,954,000 | -450,000 | 619,000 | 153,532,000 |
| Creditors | 3,745,000 | -4,116,000 | 1,192,000 | 742,000 | 4,101,000 | -1,808,000 | -1,968,000 | 301,000 | -990,000 | 539,000 | 790,000 | -121,000 | -175,000 | 379,000 | 3,291,000 |
| Accruals and Deferred Income | 226,000 | 536,000 | -15,484,000 | 10,396,000 | -4,284,000 | 2,942,000 | 1,654,000 | 1,062,000 | -37,000 | 335,000 | 363,000 | 1,162,000 | 1,329,000 | 1,839,000 | 12,536,000 |
| Deferred Taxes & Provisions | -928,000 | 1,756,000 | 2,180,000 | 1,260,000 | 869,000 | 838,000 | 1,518,000 | 0 | 0 | -4,114,000 | 462,000 | 288,000 | 433,000 | 425,000 | 2,506,000 |
| Cash flow from operations | 10,567,000 | 9,264,000 | -4,831,000 | 20,232,000 | 5,921,000 | 10,219,000 | 10,206,000 | 7,272,000 | 7,111,000 | -2,923,000 | 5,563,000 | 14,174,000 | 1,888,000 | 1,620,000 | -136,373,000 |
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 31,246,000 |
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 1,821,000 | 547,000 | 1,426,000 | 23,000 | -2,956,000 | 2,007,000 | 884,000 | 69,000 | 22,000 | 174,000 | -154,000 | -10,395,000 | 1,913,000 | 1,894,000 | 7,241,000 |
| Other Short Term Loans | 2,092,000 | 1,686,000 | 152,000 | -700,000 | 1,222,000 | -350,000 | 1,234,000 | 580,000 | 218,000 | -410,000 | 372,000 | 692,000 | 1,101,000 | 484,000 | 2,626,000 |
| Long term loans | -12,647,000 | -14,742,000 | -8,861,000 | -11,711,000 | -10,799,000 | -8,507,000 | -15,713,000 | -6,516,000 | -8,494,000 | 34,561,000 | -5,423,000 | -4,719,000 | -4,085,000 | -2,988,000 | 165,170,000 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||||||
| interest | 2,299,000 | 1,874,000 | 2,074,000 | 2,455,000 | 2,286,000 | 2,156,000 | 2,053,000 | 2,130,000 | 1,995,000 | 1,773,000 | 1,624,000 | 1,739,000 | 1,654,000 | 1,652,000 | 1,846,000 |
| cash flow from financing | -5,199,000 | -6,259,000 | -2,858,000 | -6,173,000 | -7,344,000 | -3,062,000 | -4,192,000 | -4,981,000 | -4,251,000 | 4,552,000 | -3,581,000 | -12,683,000 | 583,000 | 1,042,000 | 178,561,000 |
| cash and cash equivalents | |||||||||||||||
| cash | 6,096,000 | -11,813,000 | -7,704,000 | 10,790,000 | -9,747,000 | 7,139,000 | 5,105,000 | -2,578,000 | -2,480,000 | 106,000 | -1,033,000 | 1,476,000 | 1,500,000 | 1,557,000 | 9,377,000 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 6,096,000 | -11,813,000 | -7,704,000 | 10,790,000 | -9,747,000 | 7,139,000 | 5,105,000 | -2,578,000 | -2,480,000 | 106,000 | -1,033,000 | 1,476,000 | 1,500,000 | 1,557,000 | 9,377,000 |
the hospital company (swindon & marlborough) limited Credit Report and Business Information
The Hospital Company (swindon & Marlborough) Limited Competitor Analysis
Perform a competitor analysis for the hospital company (swindon & marlborough) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in BS1 area or any other competitors across 12 key performance metrics.
the hospital company (swindon & marlborough) limited Ownership
THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED group structure
The Hospital Company (Swindon & Marlborough) Limited has no subsidiary companies.
Ultimate parent company
SEMPERIAN PPP INVESTMENT PARTNERS HOLDIN
#0062968
2 parents
THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED
03824242
the hospital company (swindon & marlborough) limited directors
The Hospital Company (Swindon & Marlborough) Limited currently has 3 directors. The longest serving directors include Mr Richard Little (May 2013) and Mr Christopher Blundell (Nov 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Richard Little | United Kingdom | 45 years | May 2013 | - | Director |
| Mr Christopher Blundell | United Kingdom | 58 years | Nov 2018 | - | Director |
| Mr Louis Falero | England | 47 years | Dec 2022 | - | Director |
P&L
March 2024turnover
35.1m
+12%
operating profit
4.9m
+31%
gross margin
18.9%
+16.12%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
1.8m
-1.79%
total assets
129.8m
-0.01%
cash
7.8m
+3.6%
net assets
Total assets minus all liabilities
the hospital company (swindon & marlborough) limited company details
company number
03824242
Type
Private limited with Share Capital
industry
86102 - Medical nursing home activities
incorporation date
August 1999
age
26
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
PRICEWATERHOUSECOOPERS LLP
address
third floor broad quay house, prince street, bristol, BS1 4DJ
Bank
-
Legal Advisor
-
the hospital company (swindon & marlborough) limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to the hospital company (swindon & marlborough) limited. Currently there are 4 open charges and 4 have been satisfied in the past.
the hospital company (swindon & marlborough) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE HOSPITAL COMPANY (SWINDON & MARLBOROUGH) LIMITED. This can take several minutes, an email will notify you when this has completed.
the hospital company (swindon & marlborough) limited Companies House Filings - See Documents
| date | description | view/download |
|---|
